T1&T2DM management Flashcards
Pancreatic beta cell deficiency causing hypoinsulinaemia and hyperglucagonaemia
T1DM
Insulin resistance causing hypoinsulinaemia
T2DM
Role of insulin and glucagon in response to homeostasis
Stimuli: Low BSL
Alpha cell in pancreas release glucagon into the bloodstream stimulating the breakdown and release of glycogen in the liver, therefore raises BSL to normal lvl.
Stimuli: High BSL
Beta cell in pancreas release insulin into the bloodstream attaching to insulin receptors of muscles and tissues stimulating the uptake of glucose from the blood therefore lowers BSL.
form of diabetes diagnosed during pregnancy
gestational diabetes
__________develops in baby and _____________ during post delivery. Gestational diabetes can develop ____________ later in life.
hyperinsulinaemia (high BSL of mother can bring extra glucose to baby causing extra weight)
hypoglycaemia
T2DM
Main treatment for T1DM
Insulin only!
Main treatment for T2DM
Lifestyle management
oral hypoglycaemics
Lifestyle management for chronic conditions - DM
exercise
get enough sleep
reduce stress
healthy diet (limit sugar and starch)
have fun
Oral hypoglycaemics
Metformin
SGLT-2 inhibitors
Sulphonylureas
Thiazolidinediones
Metformin pharmacodynamics
GI: decrease glucose absorption and increases anaerobic glucose metabolism
Liver: decrease gluconeogenesis, glycogenolysis, fatty acid oxidation
Skeletal muscle: increase insulin-mediated glucose uptake, increase glycogenesis (storing of excess glucose)
upregulates GLUT4 transporter (act as insulin, up-taking excess glucose to muscle and fat tissues)
Metformin benefits
NO weight gain
POSITIVE EFFECTS on cholesterol levels
DO NOT CAUSE hypoglycaemia
Metformin adverse effects
GI discomfort (N&V)
increase risk of lactic acidosis
CAUTION with people with renal failure
Metformin only works in the presence of ______________
insulin
Metformin can be used for T1DM to
decrease risk of insulin resistance or T2DM (double diabetes)
SGLT-2 inhibitors pharmacodynamics
inhibit SGLT-2 transporter which allows glucose reabsorption in the kidneys. As a result, increases urinary glucose excretion
SGLT-2 inhibitor medication
dapagliflozin - only for T2DM
SGLT-2 inhibitors benefits
lowers BSL and BP
weight loss
good for cholesterol levels
unlikely to cause hypoglycaemia
SGLT-2 adverse effects
UTIs
candidiasis (fungal infection)
polyuria and polydipsia
hypotension
acute renal injury
risk of ketoacidosis
Incretins: GLP1R agonist and DPP4 inhibitors pharmacodynamics
GLP1R agonises GLP1 (hormone released by GIT) which stimulates insulin to increase glucose uptake. Decrease stimulation of glucagon which decreases hepatic gluconeogenesis
DPP4 inhibits DPP4 enzyme which destroys GLP1
Incretins benefits
decrease BSL
no hypoglycaemia
weight loss
reduced appetite
protect beta cells
positive effects on cholesterol levels
incretins adverse effects
GI upset
NOT FOR PREGNANCY and LACTATION
Liver disfunction
slows gastric emptying
pancreatitis
Sulphonylureas pharmacodynamics
closes potassium channels in the beta cells stimulating more insulin release
sulfonylureas adverse effects
GI upset
HYPOGLYCAEMIA
weight gain
allergic reactions to sulfonamide
hepatitis
photosensitivity
blood dyscrasias
sulfonylureas nursing considerations
TAKE WITH FOOD
ONE daily doses
DONT TAKE WITH NSAIDS (increase risk of HYPO)